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Abstract
Background: Heme oxygenase-1 (HO-1), an antioxidant defense enzyme, has been shown to protect against
oxidant-induced liver injury. However, its role on liver fibrosis remains unclear. This study aims to elucidate the
effect and the mechanism of HO-1 in nutritional fibrosing steatohepatitis in mice.
Methods: Male C57BL/6J mice were fed with a methionine-choline deficient (MCD) diet for eight weeks to induce
hepatic fibrosis. HO-1 chemical inducer (hemin), HO-1 chemical inhibitor zinc protoporphyrin IX (ZnPP-IX) and/or
adenovirus carrying HO-1 gene (Ad-HO-1) were administered to mice, respectively. Liver injury was assessed by
serum ALT, AST levels and histological examination; hepatic lipid peroxides levels were determined; the expression
levels of several fibrogenic related genes were assayed by real-time quantitative PCR and Western blot.
Results: MCD feeding mice showed progressive hepatic injury including hepatic steatosis, inflammatory infiltration
and fibrosis. Induction of HO-1 by hemin or Ad-HO-1 significantly attenuated the severity of liver injury. This effect
was associated with the up-regulation of HO-1, reduction of hepatic lipid peroxides levels, down-regulation of
inflammatory factors tumor necrosis factor-alpha, interleukin-6 and suppressor of cytokine signaling-1 as well as the
pro-fibrotic genes alpha-smooth muscle actin, transforming growth factor-b1, matrix metallopeptidase-2 and matrix
metallopeptidase-9. A contrary effect was observed in mice treated with ZnPP-IX.
Conclusions: The present study provided the evidence for the protective role of HO-1 in ameliorating MCD diet-
induced fibrosing steatohepatitis. Modulation of HO-1 expression might serve as a therapeutic approach for fibrotic
steatohepatitis.
Introduction
Non-alcoholic steatohepatitis (NASH) represents a
major medical problem worldwide and has been recog-
nized as a leading cause of liver fibrosis [1]. In patients
with NASH, approximately 74% and 30% progresses to
fibrosis and cirrhosis [2,3]. Although the progression of
fibrosis is the critical pathophysiological feature of
NASH, the mechanism of fibrogenesis in the presence
of steatohepatitis has not been well elucidated and spe-
cific therapies are lacking. Reactive oxygen species
(ROS) and oxidative stress are the major causes of liver
damage and involved in the development of hepatic
fibrosis by inducing hepatic stellate cells (HSC) prolif-
eration and collagen synthesis [4]. Oxidative stress also
promotes pro-inflammatory cytokines secretion, such as
tumor necrosis factor-alpha (TNF-a)a n di n t e r l e u k i n - 6
(IL-6), which are able to stimulate collagen synthesis
[5,6]. Suppressor of cytokine signaling-1 (SOCS-1) was
an important inhibitor of inflammation. It inhibits the
signaling pathway of many cytokines such as IL-2, IL-6,
TNF-a,I F N - a and IFN-g [7] and influences the inflam-
mation and fibrosis of liver [8]. It is known that activa-
tion of HSCs is a critical step in hepatic fibrogenesis.
HSCs activation is regulated by cytokines and ROS
released by damaged hepatocytes and activated Kupffer
cells and even HSCs themselves [9,10]. Once activated,
HSCs transform into proliferative, fibrogenic, and con-
tractile myofibroblasts and secrete excessive extracellular
matrix (ECM) components [11]. ECM, which is a reser-
voir for growth factors and matrix metalloproteinases
(MMPs), has been shown to actively participate in the
progression of liver fibrosis by providing survival factors
for activated HSCs [12]. The excess deposition of ECM
can disrupt the normal architecture of the liver resulting
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suppression oxidative stress, inhibition of HSC activa-
tion and its related subsequent events, such as increased
production of ECM components and fibrogenic cyto-
kines, could be a therapeutic approach for liver fibrosis.
Heme oxygenase (HO) is the rate-limiting enzyme for
heme degradation in mammals. It can metabolize the
oxidative degradation of heme into equimolar amounts
of biliverdin/bilirubin, carbon monoxide (CO), and free
iron [13]. Three isoforms of HO have been characterized:
the stress-inducible protein HO-1, widely expressed at a
low level in mammalian tissues and can be induced by a
variety of stimuli, including heme, heavy metals, cyto-
kines, endotoxins and oxidative stress [14]; the constitu-
tive HO-2, expressed mainly in the brain and testis and is
unresponsive to any of the known HO-1 inducers [15];
and the HO-3, who shares about 90% amino acid homol-
ogy with HO-2, has a very low enzyme activity and con-
stitutively expressed in the liver in rats [16]. HO-1 occurs
at low to undetectable levels in live and expresses mainly
in Kupffer cells under basal conditions, but it undergoes
a rapid transcriptional activation and expresses in both
Kupffer cells and hepatocytes as response to noxious sti-
muli [17]. HO-1 induction is considered to be an adap-
tive cellular response to survive exposure to
environmental stresses. Although the function of this
enzyme is not completely understood, increasing evi-
dence suggests that HO-1 plays a vital role in many
aspects, such as suppression of oxidative stress, inflam-
mation and cell proliferation, microcirculation improve-
ment and regulation of cytokine expression in various
pathological conditions [18-20]. However, there are few
investigations regarding the protective effect of HO-1 on
liver fibrosis. Importantly, no evidence is available for
whether the expression of HO-1 contributes to the
pathophysiological changes in the development of nutri-
tional fibrosing steatohepatitis. Thus, the present study
was designed to investigate the effects of HO-1 expres-
sion on liver fibrosis induced by MCD diet in mice.
Materials and methods
Animals and treatments
Eight-week-old male C57BL/6J mice were obtained from
the Experimental Animal Center of the Chinese Academy
of Medical Sciences, and were bred in a temperature-
controlled animal facility with a 12-h light-dark cycle.
The animals had free access to water and were allowed to
adapt to their food and environment for 1 week before
the start of the experiment. Mice were randomly divided
into 7 groups (6 mice per group): 1) MCD group, mice
fed methionine-choline deficient diet (ICN, Aurora,
Ohio, USA); 2) control group, mice fed MCD diet supple-
mented with choline bitartate(2 g/kg) and DL-methio-
nine (3 g/kg) (ICN, Aurora, Ohio); 3) MCD+hemin
group, mice fed MCD diet administered with HO-1 che-
mical inducer hemin (30 μmol/kg) by intraperitoneal
(i.p.) injections three times per week; 4) MCD+ZnPP
group, mice fed MCD diet administered with HO-1 inhi-
bitor ZnPP-IX (20 μmol/kg) by i.p. injections three times
per week; 5) MCD+Ad-GFP group, mice fed MCD diet
administered with adenovirus encoding green fluorescent
protein (2.5 × 10
8 Plaque-forming units (pfu) by i.p.
injections two times per week; 6) MCD+Ad-HO-1 group,
mice fed MCD diet administered with adenovirus encod-
ing the full-length mouse HO-1(2.5 × 10
8 pfu) (Ad-HO-1)
by i.p. injections two times per week; 7) MCD+hemin+
Ad-HO-1 group, mice fed MCD diet administered with
hemin and Ad-HO-1. The duration of the experiment is
up to 8 weeks. During the experiments, the body-weight
and rate of diet consumption were recorded. At the end
of the experiment, all of the animals were sacrificed after
overnight fasting. Blood samples were collected from the
femoral artery for biochemical analysis. Livers were
weighed and fixed in 10% formalin for histological analy-
sis, or snap-frozen in liquid nitrogen followed by storage
at -80°C freezer until required. All the protocols and pro-
cedures were carried out in accordance with the guide-
lines of the Hebei Committee for Care and Use of
Laboratory Animals and were approved by the Animal
Experimentation Ethics Committee of the Hebei Medical
University.
Construction of recombinant adenoviru
A recombinant adenovirus containing the entire coding
sequence of mouse HO-1 (Ad-HO-1) and control ade-
novirus encoding green fluorescent protein (Ad-GFP)
were purchased from Tianjing Saier Biochemistry lim-
ited company (Tianjing, China). Adenovirus was propa-
gated, isolated in human embryonic kidney 293 (HEK
293) cells and purified with Adeno-X Virus Purification
kit (Clontech, Mountain View, CA, USA). Titer of the
viral solution was determined by Adeno-X Rapid Titer
kit (Clontech). The virus wass t o r e da t- 8 0 ° Cu n t i lu s e .
Mice were given intraperitoneal injection of Ad-HO-1
or Ad-GFP at an amount of 2.5 × 10
8 pfu suspended in
100 μl phosphate-buffered saline two times per week.
Measurement of serum ALT and AST
Serum alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) levels were measured by the
enzymatic kinetic method using an automatic biochem-
ical analyzer (Olympus UA2700, Japan) according to the
manufacturer’s instructions.
Histologic evaluation
Formalin-fixed liver was embedded in paraffin and 4 μm
sections were stained with Haematoxylin and eosin and
Masson-trichrome. Two experienced hepatopathologist
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for steatosis and fibrosis as described previously [21].
The stage of fibrosis was assessed using a 4-point scale
(1, mild/moderate zone 3 perisinusoidal fibrosis, or por-
tal fibrosis only; 2, zone 3 and portal/periportal fibrosis;
3, bridging fibrosis; and 4, cirrhosis).
Malondialdehyde (MDA) assay
The extent of lipid peroxidation in the liver homogenate
was evaluated by measuring the concentration of the
thiobarbituric acid-reactive product, malondialdehyde
(MDA), using a thiobarbituric acid-reactive substrances
(TBARS) assay kit (Cell Biolabs, Inc. San Diego, CA) [22].
Hydroxyproline Analysis
The degree of liver fibrosis was determined by the mea-
surement of hydroxyproline content in livers (Jiancheng
Bioengineering, Nanjing, China), which could represent
the total amount of collagens in livers. The experiment
was performed as previously described [23]. The hydro-
xyproline levels in the hydrolysates were measured by
detection of the absorbance at 550 nm. A standard
curve of samples with known quantities of hydroxypro-
line was generated for each assay. The absorbances of
unknown samples were compared to the standard curve,
hydroxyproline content was calculated and expressed as
microgram hydroxyproline/milligram liver. Each sample
was assayed in triplicate.
Quantitation of hepatic messenger RNA expression levels
Total RNA was extracted from the frozen liver tissues by
using RNA Trizol reagent (Invitrogen, Carlsbad, CA).
Five microgram of total RNA for each sample was reverse
transcribed into complementary DNA (cDNA), the
c D N Aw a sd i l u t e d1 / 1 0 0a n d5μl were used as a tem-
plate per PCR reaction. The quantitative real-time PCR
was performed on an ABI PRISM 7300 PCR System
(Applied Biosystems, Foster City, CA) using Syber Green
I GoTaq
® qPCR Master Mix (Promega BioSciences. Sun-
nyvale, CA). Expression levels of the target genes gener-
ated standard curves were normalized against an
endogenous reference gene glyceraldehydes 3-phosphate
dehydrogenase (GAPDH). For each sample and each
gene, PCR were carried out in duplicate and repeated
twice. The relative expression of target genes were
obtained by the software SDS v1.3.2 attached with the
PCR machine. Levels of mRNA expression of TNF-a, IL-
6 and SOCS1 were also determined by reverse transcrip-
tion semi-quantitative polymerase chain reaction (RT-
PCR) in a 25 μl reaction volume using Promega Green
Master Mix (Promega, San Luis Obispo, CA) on the ABI
Prism 2720 (Applied Biosystems, Foster City, CA). The
specific primer sequences were listed in Table 1.
Western blotting analysis of hepatic protein expression
Total protein was extracted and concentration was
measured by the Bradford method (DC protein assay;
B i o - R a d ,H e r c u l e s ,C A ) .E q u a la m o u n t so fp r o t e i n
(100 μg/well) were loaded onto 10% SDS-PAGE for
each sample and proteins were transferred onto equili-
brated polyvinylidene difluoride membranes (Amer-
sham Biosciences, Buckinghamshire, UK) by
electroblotting. Membranes were incubated overnight
at 4°C with primary antibodies (Santa Cruz Biotech-
n o l o g y ,S a n t aC r u z ,C A ) .A f t e ri n c u b a t i o nw i t ht h e
secondary antibody, proteins were detected by
enhanced chemiluminescence (ECL, Amersham Cor-
poration). The amount of protein expression was cor-
rected by the amount of b-actin in the same sample
and the bands were quantified by scanning densitome-
try using the digital Kodak Gel Logic 200 (Carestream
Molecular Imaging, USA).
Statistical analysis
All data are expressed as mean ± standard deviation
(SD). Statistical analysis was carried out by one-way ana-
lysis of variance (ANOVA) and the Student-Newman-
Keuls test for evaluating differences between groups
using SPSS 13.0 (v.13.0; SPSS Inc., Chicago, III, USA). A
P-value of less than 0.05 was considered statistically
significant.
Table 1 Primers for real-time quantitative PCR analysis
Gene Product length Primer sequences
HO-1 427bp F 5’-AACAAGCAGAACCCAGTCTATG-3’
R5 ’-TGAGCAGGAAGGCGGTCTTA-3’
TNF-a 300bp F 5’-GGCAGGTCTACTTTGGAGTCATTGC-3’
R5 ’-ACATTCGAGGCTCCAGTGAATTCGG-3’
IL-6 159bp F 5’-AGT TGC CTT CTT GGG ACT GA-3’
R5 ’-TCC ACG ATT TCC CAG AGA AC-3’
a-SMA 160bp F 5’-CTGACAGAGGCACCACTGAA-3’
R5 ’-CATCTCCAGAGTCCAGCACA-3’
TGF-b1 272bp F 5’-CAACGCCATCTATGAGAAAACC-3’
R5 ’-ACTGCCGTACAACTCCAGTGAC-3’
MMP-2 203bp F 5’-CACACCAGGTGAAGGATGTG-3’
R5 ’-AGGGCTGCATTGCAAATATC-3’
MMP-9 67bp F 5’-CAGTATCTGTATGGTCGTGGCT-3’
R5 ’-TTCAGTTGTGGTGGTGGCT-3’
SOCS1 123bp F 5’-TCCTCGTCCTCGTCTTCGT-3’
R5 ’-TAATCGGAGTGGGAGCGGA-3’
GAPDH 450bp F 5’-ACCACAGTCCATGCCATCAC-3’
R5 ’-TCCACCACCCTGTTGCTG-3’
Abbreviations: HO-1, heme oxygenase-1; TNF-a, tumor necrosis factor-alpha;
IL-6, interleukin-6; a-SMA, a-smooth muscle actin; TGF-b1, transforming
growth factor beta 1; MMP-2, matrix metallopeptidase-2; MMP-9, matrix
metallopeptidase-9; SOCS1, suppressor of cytokine signaling-1; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase.
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Effect of HO-1 on MCD diet-induced fibrosing
steatohepatitis
Mice fed with MCD diet for 8 weeks exhibited disor-
dered lobule structure, macrosteatosis in Zone 3, spot
or focal hepatocyte necrosis, inflammatory infiltration
(Figure 1A) and portal and perisinusoidal fibrosis (Fig-
ure 1B). Treatment with HO-1 inducer hemin or Ad-
HO-1 markedly reduced the severity of hepatic steatosis,
inflammatory infiltration (Figure 1A) and fibrosis (Figure
1B), which was associated with a prominent decrease in
serum ALT (Figure 2A), AST (Figure 2B) levels and
hepatic hydroxyproline content (Figure 3A). Co-admin-
istration of hemin and Ad-HO-1 gave similar effect
without further improvement. In contrast, hepatic
steatosis, inflammatory infiltration and fibrosis were
aggravated (Figure 1), the serum transaminases levels
(Figure 2) and hepatic hydroxyproline content (Figure
3A) were further elevated in mice treated with ZnPP-IX
than those fed MCD diet only. These showed that HO-1
induction protected mice from MCD diet-induced liver
injury.
Effect of HO-1 induction on liver malondialdehyde
Malondialdehyde (MDA) was analyzed as an indicator of
lipid peroxidation. Mice intake of the MCD diet resulted
in a significant increase in hepatic MDA content com-
pared with that of the control mice, indicating hepatic
oxidative stress. An impressive reduction of hepatic
MDA was noted after hemin treatment for 8 weeks
Figure 1 Histopathological changes of liver sections of mice under various treatment conditions. Hematoxylin and eosin stained (A) and
Masson trichromatism stained (B) liver sections from mice livers (Original magnification, ×200).
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observed by Ad-HO-1 gene transfer compared to mice
administered Ad-GFP. The combination of hemin and
Ad-HO-1 failed to show an additive effect on suppressing
MDA concentrations. However, the levels of hepatic
MDA was significantly increased in mice treated with
ZnPP-IX than those fed MCD diet only (Figure 3B). Mea-
surement of hepatic MDA revealed that HO-1 induction
ameliorated oxidative injury induced by MCD feeding.
Induction of HO-1 by hemin and/or Ad-HO-1
The mRNA and protein expression of HO-1 was barely
detectable in mice fed control diet, increased in mice
fed the MCD diet and markedly increased in mice trea-
ted with hemin or Ad-HO-1 (Figure 4), which paralleled
the improvement in histological severity of steatohepati-
tis. Co-administration of hemin and Ad-HO-1 had no
better effect on up-regulation of HO-1 expression.
Conversely, in ZnPP-IX treatment mice, hepatic mRNA
and protein expression of HO-1 was inhibited in com-
pany with a pronounced liver injury (Figure 4).
Effect of HO-1 on the expression of inflammatory genes
To seek an explanation for the decreased serum transami-
nases and ameliorated liver histology by inducing HO-1,
we investigated hepatic messenger RNA (mRNA) expres-
sion levels of inflammatory genes TNF-a,I L - 6a n d
SOCS1. Relative to control mice, Hepatic TNF-a,I L - 6
and SOCS1 genes were up-regulated in MCD diet-fed
mice (Figure 5). This induction was significantly blunted
by the treatment with hemin or Ad-HO-1. The combina-
tion of hemin and Ad-HO-1 caused similar effects on pre-
venting the TNF-a, IL-6 and SOCS1 mRNA expression.
Whereas, supplement with ZnPP-IX led to a further
increase of TNF-a, IL-6 and SOCS1 expression compared
with mice fed MCD diet only (Figure 5).
Figure 2 Effects of the MCD diet and treatment with hemin and/or Ad-HO-1 or ZnPP-IX on: (A) Serum alanine aminotransferase (ALT);
(B) Serum aspartate aminotransferase (AST). Data are expressed as mean ± SD (n = 6 per group). *P < 0.001, compared with control group;
#P < 0.05,
##P < 0.01,
###P < 0.001, compared with MCD group;
$P < 0.001, compared with MCD+Ad-GFP group.
Figure 3 Effects of MCD diet and treatment with hemin and/or Ad-HO-1 or ZnPP-IX on: (A) liver hydroxyproline content; (B) hepatic
malondialdehyde (MDA) content. Data are expressed as mean ± SD (n = 6 per group). *P < 0.01, **P < 0.001, compared with control group;
#P < 0.05,
##P < 0.01, compared with MCD group;
$P < 0.05, compared with MCD+Ad-GFP group.
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To evaluate the mechanisms of the effect of HO-1
induction on fibrosing steatohepatitis, we assessed the
hepatic expression level of fibrosis related genes. Mice
fed a MCD diet showed enhanced expression of hepatic
mRNA and protein of alpha-smooth muscle actin (a-
SMA) (Figure 6A), transforming growth factor-b1 (TGF-
b1) (Figure 6B), matrix metallopeptidase-2 (MMP-2)
(Figure 7A) and matrix metallopeptidase-9 (MMP-9)
(Figure 7B), which was significantly blunted by the treat-
ment with hemin or Ad-HO-1. A similar effect was
observed in hemin plus Ad-HO-1 group. Conversely,
hepatic mRNA and protein expressions of a-SMA,
TGF-b1 (Figure 6), MMP-2 and MMP-9 (Figure 7) were
further up-regulated by ZnPP-IX treatment as compared
to MCD group.
Discussion
With use of the MCD dietary model, mice consistently
develop a form of fibrosing steatohepatitis. The resulting
characteristic pathology of steatosis mixed inflammatory
cell infiltrate, hepatocyte necrosis, and appreciable intra-
parenchymal pericellular fibrosis mimics the finding in
human NASH [24]. In addition, MCD diet caused
Figure 4 Effects of hemin and/or Ad-HO-1 on hepatic HO-1 mRNA and protein expression in the livers of mice. (A) Hepatic HO-1 mRNA,
determined by real-time quantitative PCR; (B) HO-1 protein levels, detected by Western blot. Data are expressed as the mean ± SD (n = 6 per
group). *P < 0.01, **P < 0.001, compared with control group;
#P < 0.05,
##P < 0.01,
###P < 0.001, compared with MCD group;
$P < 0.01,
$$P <
0.001, compared with MCD+ Ad-GFP group.
Figure 5 Effects of HO-1 on hepatic inflammatory factors in MCD diet-induced fibrosing steatohepatitis. (A) Hepatic TNF-a mRNA levels
were determined by (A1) RT-PCR and (A2) real-time quantitative PCR; (B) Hepatic interleukin-6 (IL-6) mRNA levels, determined by (B1) RT-PCR
and (B2) real-time quantitative PCR; (C) Hepatic SOCS1 mRNA levels were determined by (C1) RT-PCR and (C2) real-time quantitative PCR. Data
are expressed as the mean ± SD (n = 6 per group). *P < 0.001, compared with control group;
#P < 0.05,
##P < 0.01, compared with MCD group;
$P < 0.05,
$$P < 0.01,
$$$P < 0.001, compared with MCD+ Ad-GFP group.
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tic hydroxyproline concentrations in C57BL/6J mice.
Taking ALT and AST as reliable indicators of liver
inflammatory injury and hepatic hydroxyproline as the
amount of collagen fibers, we found that hepatic inflam-
mation and fibrosis were alleviated via hemin or Ad-
HO-1 treatment. However, the combination of Ad-HO-
1 and hemin did not further ameliorate the liver injury.
On the other hand, treatment with HO-1 chemical inhi-
bitor ZnPP-IX down-regulated the expression of HO-1
and augmented the liver injury. Wei et al. [25] found
that HO-1 was expressed at a high level in the early or
initiation stage of cirrhosis, and AST kept at a marked
low level [26]. These indicated that HO-1 might play an
important role in prevention of hepatic inflammation
and fibrosis.
Oxidative stress is an essential “second hit” in the
pathogenesis of NASH, because increased free radicals
can cause lipid peroxidation which induces inflamma-
tory response and stellate cells activation, and further
leads to collagen synthesis and fibrogenesis [27]. The
antioxidant defense mechanism was altered by accumu-
lation of the products derived from oxidative damage
such as malondialdehyde (MDA) [28]. MDA can pro-
duce ozone, hydrogen peroxide and other active oxygen
species, cause peroxidation and denaturation of cellular
membranes [29], which impact on the HSCs to induce a
fibrogenic response [6]. In the present study, we found
that up-regulation of HO-1 by hemin or Ad-HO-1
could decrease the hepatic MDA levels, improve the
hepatic oxidative damage in MCD diet induced fibrosing
steatohepatitis. Xue and colleagues [30] found that HO-
Figure 6 Effects of HO-1 on a-SMA and TGF-b1 expression in MCD diet-induced fibrosing steatohepatitis. mRNA expression of a-SMA
(A1) and TGF-b1 (B1) were determined by real-time quantitative PCR; protein levels of a-SMA (A2) and TGF-b1 (B2) were detected by Western
blot. Data are expressed as the mean ± SD (n = 6 per group). *P < 0.001, compared with the control group;
#P < 0.05,
##P < 0.01,
###P < 0.001,
compared with MCD group;
$P < 0.01,
$$P < 0.001, compared with MCD+Ad-GFP group.
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injury in cirrhotic rats by lowering serum MDA and
increasing serum manganese superoxide dismutase
(MnSOD). The protective effects of HO-1 may be due
to its antioxidative product biliverdin/bilirubin, which
can scavenge peroxide radicals and inhibit lipid peroxi-
dation [14]. Therefore, we speculate that high HO-1
expression induced by hemin or Ad-HO-1 appears to be
a good choice for preventing the oxidative injury in
fibrosing steatohepatitis.
Normally, oxidative injury leads to damage of hepato-
cytes, which is followed by activation of Kupffer cells
and result in production of a number of inflammatory
cytokines, including TNF-a and IL-6 [12]. This regula-
tion might explain the enhancement of hepatic TNF-a
a n dI L - 6m R N Ae x p r e s s i o ni nM C Df e dm i c e .I n
response to proinflammatory cytokines of TNF-a and
IL-6, the mRNA expression of SOCS1 is also increased
in MCD fed mice. Induction of SOCS-1 is likely respon-
sible for the hepatic inflammatory injure in the MCD
fed mice. While SOCS-1 was not sufficient enough to
inhibit the inflammatory injure that have been induced
by MCD [31]. Up-regulation of HO-1 by hemin and
Ad-HO-1 could improve the hepatic inflammation. The
expression of SOCS-1 was correlated with the improved
hepatic inflammatory injury. This anti-inflammatory
effect might due to the decreased expression of hepatic
TNF-a and IL-6 mRNA. In keeping with our findings,
Wei et al. [24] reported that exposure of the liver to car-
bon tetrachloride (CCl4) was associated with inflamma-
tory cell infiltration, which was attenuated in hemin-
pretreated CCl4-exposed animals. Furthermore, Kim et
Figure 7 Effects of HO-1 on MMP-2 and MMP-9 expression in MCD diet-induced fibrosing steatohepatitis. mRNA expression of MMP-2
(A1) and MMP-9 (B1) were determined by real-time quantitative PCR; protein levels of MMP-2 (A2) and MMP-9 (B2) were detected by Western
blot. Data are expressed as the mean ± SD (n = 6 per group). *P < 0.001, compared with the control group;
#P < 0.05,
##P < 0.01,
###P < 0.001,
compared with MCD group;
$P < 0.01,
$$P < 0.001, compared with MCD+Ad-GFP group.
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expression and reduced adipogenesis in Zucker rats
[32]. Thus, a reduction of inflammation induced by HO-
1 achieved by inhibiting release of the inflammatory
mediators, finally relieved hepatic inflammatory damage
and fibrosis.
Following sustained oxidative stress and inflammatory
injury, HSCs become activated and transdifferentiate
into myofibroblasts [33]. The activation of HSCs, a key
issue in the pathogenesis of hepatic fibrosis [34], is
mediated by various cytokines and ROS released from
the damaged hepatocytes and activated Kupffer cells.
Moreover, HSCs are the primary target cells for inflam-
matory stimuli [35]. In this study, the mRNA and pro-
tein expression of a-SMA, a biomarker of activated
HSCs, showed a prominent increase in the livers of
MCD diet mice, indicating an increase of stellate cell
activation. Administration of hemin or Ad-HO-1 could
reduce the expression of a-SMA, suggesting that the
HSCs activation was inhibited by HO-1. It has been
shown that induction of HO-1 by hemin blunted hepatic
myofibroblasts proliferation and procollagen I mRNA
expression, which implicated that HO-1 was a major
antifibrogenic pathway in human hepatic myofibroblasts
[36]. To clarify the mechanism by which the MCD diet
caused hepatic fibrosis in mice, the expression of TGF-
b1, one of the central fibrogenic factors involved in the
process of myofibroblast activation and collagen synth-
esis in the liver was estimated [37]. The mRNA and pro-
tein expression of TGF-b1 were increased in the livers
of MCD fed mice, and further up-regulated in ZnPP-IX
treatment mice. However, up-regulation of HO-1 by
hemin or Ad-HO-1 favorably modulated the TGF-b1
expression. This effect was supported by observations
that the overexpression of HO-1 could exert its inhibi-
tory effects on the transcript activities of TGF-b1i n
adeno-associated virus-mediated HO-1(rAAV/HO-1)-
transduced animals [38]. On this basis, Up-regulation of
HO-1 might function as a negative regulator in the con-
trol of fibrogenic activities of HSCs.
In addition to being a major source of ECM produc-
tion, activated HSCs also show increased expression of
MMP-2 and MMP-9, which can degrade several compo-
nents of the normal liver matrix, including collagen IV,
laminin, and fibronectin, and are important in the
remodeling of matrix during tissue repair processes
[39]. It was likely that degradation of the ECM by
MMP-2 and MMP-9 altered cell-matrix and cell-cell
interactions and enhanced hepatocyte susceptibility to
necrosis [40], and HO-1 introduction might attenuate
this process by decreasing MMP-2 and MMP-9 expres-
sion. Similar results have been obtained from the find-
ings that the reversion of myocardial extracellular
remodeling in the heart treated by Ad-hHO-1-
transfected mesenchymal stem cells was also accompa-
nied by a decrease of MMP-2 and MMP-9 expression,
suggesting that HO-1 overexpression confered anti-
fibrogenic property [41].
In conclusion, the present study showed that up-regu-
lation of HO-1 provided a beneficial role in modulating
oxidative stress, inflammatory insult and HSCs activa-
tion in the livers with fibrosing steatohepatitis. This
effect was associated with the decreased expression of
inflammatory cytokines TNF-a,I L - 6 ,S O C S 1a n dp r o -
fibrogenic factors a-SMA, TGF-b1, MMP-2 and MMP-
9. Clearly, further studies are still necessary to clarify at
which level HO-1 plays the beneficial anti-inflammatory,
anti-oxidative stress and anti-fibrotic effects.
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